全文获取类型
收费全文 | 1431篇 |
免费 | 99篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 37篇 |
妇产科学 | 29篇 |
基础医学 | 167篇 |
口腔科学 | 17篇 |
临床医学 | 251篇 |
内科学 | 274篇 |
皮肤病学 | 29篇 |
神经病学 | 124篇 |
特种医学 | 30篇 |
外科学 | 155篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 200篇 |
眼科学 | 3篇 |
药学 | 84篇 |
肿瘤学 | 105篇 |
出版年
2023年 | 10篇 |
2022年 | 11篇 |
2021年 | 42篇 |
2020年 | 31篇 |
2019年 | 37篇 |
2018年 | 44篇 |
2017年 | 32篇 |
2016年 | 32篇 |
2015年 | 29篇 |
2014年 | 44篇 |
2013年 | 55篇 |
2012年 | 91篇 |
2011年 | 105篇 |
2010年 | 57篇 |
2009年 | 36篇 |
2008年 | 78篇 |
2007年 | 89篇 |
2006年 | 90篇 |
2005年 | 83篇 |
2004年 | 87篇 |
2003年 | 78篇 |
2002年 | 67篇 |
2001年 | 32篇 |
2000年 | 18篇 |
1999年 | 20篇 |
1998年 | 7篇 |
1997年 | 10篇 |
1996年 | 9篇 |
1995年 | 20篇 |
1994年 | 12篇 |
1993年 | 6篇 |
1992年 | 20篇 |
1991年 | 17篇 |
1990年 | 16篇 |
1989年 | 18篇 |
1988年 | 14篇 |
1987年 | 8篇 |
1986年 | 10篇 |
1985年 | 12篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1979年 | 3篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1969年 | 3篇 |
1968年 | 4篇 |
1967年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有1532条查询结果,搜索用时 15 毫秒
51.
Lorna Dunning Aditya R Gandhi Martina Penazzato Djra I Soeteman Paul Revill Simone Frank Andrew Phillips Caitlin Dugdale Elaine Abrams Milton C Weinstein MarieLouise Newell Intira J Collins Meg Doherty Lara Vojnov Patricia Fassinou Ekouvi Landon Myer Angela Mushavi Kenneth A Freedberg Andrea L Ciaranello 《Journal of the International AIDS Society》2021,24(1)
IntroductionUptake of early infant HIV diagnosis (EID) varies widely across sub‐Saharan African settings. We evaluated the potential clinical impact and cost‐effectiveness of universal maternal HIV screening at infant immunization visits, with referral to EID and maternal antiretroviral therapy (ART) initiation.MethodsUsing the CEPAC‐Pediatric model, we compared two strategies for infants born in 2017 in Côte d’Ivoire (CI), South Africa (SA), and Zimbabwe: (1) existing EID programmes offering six‐week nucleic acid testing (NAT) for infants with known HIV exposure (EID), and (2) EID plus universal maternal HIV screening at six‐week infant immunization visits, leading to referral for infant NAT and maternal ART initiation (screen‐and‐test). Model inputs included published Ivoirian/South African/Zimbabwean data: maternal HIV prevalence (4.8/30.8/16.1%), current uptake of EID (40/95/65%) and six‐week immunization attendance (99/74/94%). Referral rates for infant NAT and maternal ART initiation after screen‐and‐test were 80%. Costs included NAT ($24/infant), maternal screening ($10/mother–infant pair), ART ($5 to 31/month) and HIV care ($15 to 190/month). Model outcomes included mother‐to‐child transmission of HIV (MTCT) among HIV‐exposed infants, and life expectancy (LE) and mean lifetime per‐person costs for children with HIV (CWH) and all children born in 2017. We calculated incremental cost‐effectiveness ratios (ICERs) using discounted (3%/year) lifetime costs and LE for all children. We considered two cost‐effectiveness thresholds in each country: (1) the per‐capita GDP ($1720/6380/2150) per year‐of‐life saved (YLS), and (2) the CEPAC‐generated ICER of offering 2 versus 1 lifetime ART regimens (e.g. offering second‐line ART; $520/500/580/YLS).ResultsWith EID, projected six‐week MTCT was 9.3% (CI), 4.2% (SA) and 5.2% (Zimbabwe). Screen‐and‐test decreased total MTCT by 0.2% to 0.5%, improved LE by 2.0 to 3.5 years for CWH and 0.03 to 0.07 years for all children, and increased discounted costs by $17 to 22/child (all children). The ICER of screen‐and‐test compared to EID was $1340/YLS (CI), $650/YLS (SA) and $670/YLS (Zimbabwe), below the per‐capita GDP but above the ICER of 2 versus 1 lifetime ART regimens in all countries.ConclusionsUniversal maternal HIV screening at immunization visits with referral to EID and maternal ART initiation may reduce MTCT, improve paediatric LE, and be of comparable value to current HIV‐related interventions in high maternal HIV prevalence settings like SA and Zimbabwe. 相似文献
52.
53.
Bianconi SE Conley SK Keil MF Sinaii N Rother KI Porter FD Stratakis CA 《American journal of medical genetics. Part A》2011,(11):2732-2738
Smith-Lemli-Opitz syndrome (SLOS) is a multiple malformation syndrome due to mutations of the 7-dehydrocholesterol reductase gene (DHCR7), which leads to a deficiency of cholesterol synthesis and an accumulation of 7-dehydrocholesterol. The SLOS clinical spectrum ranges from multiple major malformations to a mild phenotype with minor anomalies and intellectual disability. Several children with SLOS and adrenal insufficiency have been described. We performed ovine corticotropin (oCRH) testing in 35 SLOS patients and 16 age- and gender-matched controls. We reviewed prior adrenocorticotropin (ACTH) stimulation tests of our SLOS patients (19 of 35 available) and reviewed results of ACTH stimulation tests from 10 additional SLOS patients. Results from oCRH testing showed that patients with SLOS had significantly higher ACTH baseline values than healthy controls (24.8 ± 15.3 pg/ml vs. 17.8 ± 7.5 pg/ml, P = 0.034). However, no statistically significant differences were noted for peak ACTH values (74.4 ± 35.0 pg/ml vs. 64.0 ± 24.9 pg/ml, P = 0.303) and for baseline (14.2 ± 7.8 mcg/dl vs. 14.2 ± 6.3 mcg/dl, P = 0.992) and peak cortisol values (28.2 ± 7.9 mcg/dl vs. 24.8 ± 8.1 mcg/dl, P = 0.156). The area-under-the-curve (AUC) was not significantly different in SLOS patients compared to controls for both ACTH (250.1 ± 118.7 pg/ml vs. 195.3 ± 96.6 pg/ml, P = 0.121) as well as cortisol secretion (83.1 ± 26.1 mcg/dl vs. 77.8 ± 25.9 mcg/dl, P = 0.499). ACTH stimulation test results were normal in 28 of 29 tests. The individual with the abnormal test results had subsequent normal oCRH tests. The slightly increased baseline ACTH level seen during oCRH testing may be due to compensated adrenocortical insufficiency. However, we were able to show that our patients with SLOS had an adequate glucocorticoid response, and thus, in mild to moderate cases of SLOS stress steroid coverage may not be warranted. 相似文献
54.
55.
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases 下载免费PDF全文
Niederwieser D Maris M Shizuru JA Petersdorf E Hegenbart U Sandmaier BM Maloney DG Storer B Lange T Chauncey T Deininger M Pönisch W Anasetti C Woolfrey A Little MT Blume KG McSweeney PA Storb RF 《Blood》2003,101(4):1620-1629
Toxicities of high-dose conditioning regimens have limited the use of conventional unrelated donor hematopoietic cell transplantation (HCT) to younger, medically fit patients. Based on preclinical studies, an HCT approach has been developed for elderly or medically infirm patients with HLA-matched or mismatched unrelated donors. In this study, 52 patients with hematological diseases were included. Most (88%) had preceding unsuccessful conventional HCT or refractory/advanced disease. Patients were treated with fludarabine 30 mg/m(2)/d from days -4 to -2, 2 Gy total body irradiation on day 0, cyclosporine at 6.25 mg/kg twice daily from day -3, and mycophenolate mofetil at 15 mg/kg twice daily from day 0. Durable donor chimerism was attained in 88% of the patients. By day 28, a median of 100% of CD56(+) cells were of donor origin. Granulocyte and T-cell donor chimerism increased to medians of 100% on day 56 and day 180 (range, 55%-100%), respectively. Acute GVHD, grade II, was seen in 42% (CI, 29%-56%); grade III in 8% (CI, 0%-15%); and grade IV in 13% (CI, 4%-23%) of patients; it was fatal in 9%. The 100-day transplantation-related mortality was 11%. Complete remissions, including molecular remissions, were seen in 45% of patients with measurable disease before transplantation. Mortality from disease progression was 27% at one year. With a median follow-up of 19 months, 18 of the 52 patients (35%) were alive and 25% were in remission. HCT from HLA-matched or mismatched unrelated donors can be performed with a reduced intensity conditioning regimen in patients ineligible for conventional HCT. 相似文献
56.
57.
Larry R. Gettman Thomas W. Storer Robert D. Ward 《The Physician and sportsmedicine》2013,41(9):92-101
In brief: Professional football players participated in a conditioning program before entering regular preseason training. The program comprised training in functional strength, aerobic endurance, sprinting, power, ballistics, plyometrics, and football skills. Seven fitness variables were measured at the beginning and at the end of the program: body fat, lean body weight, treadmill performance, maximum oxygen uptake, ventilatory anaerobic threshold, agility, and vertical jump. The offensive linemen, who as a group scored lowest on the pretest, improved significantly on all seven tests. 相似文献
58.
Lucianne Groenink Elisabeth Y. Bijlsma Meg J. V. van Bogaert Ronald S. Oosting Berend Olivier 《Psychopharmacology》2011,214(1):353-365
Rationale
Early life stress is a risk factor for the development of psychopathology in later life. Consequences of adverse life events, however, may depend on the genetic makeup of an individual. Reduced serotonin1A receptor function may predispose to the development of anxiety disorders. 相似文献59.
Nan Zhang Rebecca E Sadun Robyn S Arias Meg L Flanagan Suzanne M Sachsman Yu-Chih Nien Leslie A Khawli Peisheng Hu Alan L Epstein 《Clinical cancer research》2007,13(9):2758-2767
Introduction: CD137L is a member of the tumor necrosis factor superfamily that provides a costimulatory signal to T cells. In this study, two novel CD137L fusion proteins were produced and compared with the CD137 agonist antibody 2A. Materials and Methods: Murine CD137L was linked to the COOH terminus of either the Fc fragment of immunoglobulin (untargeted version) or TNT-3 (targeted version), an antibody that binds to necrotic regions of tumors. Groups of mice bearing established Colon 26 tumors were then treated daily x 5 with each fusion protein or 2A to determine their immunotherapeutic potential. RESULTS: Both fusion proteins retained CD137L activity in vitro and TNT-3/CD137L showed tumor-binding activity by biodistribution analysis in tumor-bearing mice. The fusion proteins also produced similar responses in vivo at the 1 nmol per dose range and showed a 60% (TNT-3/CD137L) or 40% (Fc/CD137L) survival of treated mice at 150 days after tumor implantation, similar to the effects of 2A. Morphologic and immunohistochemical analyses showed massive central necrosis and infiltration of granzyme B-positive cells in necrotic areas and viable peripheral regions of treated tumors. Finally, cell depletion studies showed that CD137L-mediated tumor regression was CD8(+) T cell dependent. CONCLUSIONS: From these studies, it was determined that both targeted and untargeted CD137L fusion proteins showed effective antitumor activity, but that the targeted version was more potent. Therefore, the use of the natural CD137 ligand is a promising approach to the treatment of solid tumors by virtue of its ability to produce physiologic costimulation within the tumor, limiting side effects often seen with agonist antibody therapies. 相似文献
60.